Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso

BACKGROUND: The use of pyronaridine-artesunate (PA) has been associated with scarce transaminitis in patients. This analysis aimed to evaluate the hepatic safety profile of repeated treatment with PA versus artemether–lumefantrine (AL) in patients with consecutive uncomplicated malaria episodes in B...

Descripción completa

Detalles Bibliográficos
Autores principales: Compaoré, Yves Daniel, Zongo, Issaka, Somé, Anyirékun F., Barry, Nouhoun, Nikiéma, Frederick, Kaboré, Talato N., Ouattara, Aminata, Kabré, Zachari, Wermi, Kadidiatou, Zongo, Moussa, Yerbanga, Rakiswende S., Sagara, Issaka, Djimdé, Abdoulaye, Ouédraogo, Jean Bosco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847156/
https://www.ncbi.nlm.nih.gov/pubmed/33514368
http://dx.doi.org/10.1186/s12936-021-03593-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847156/
https://www.ncbi.nlm.nih.gov/pubmed/33514368
http://dx.doi.org/10.1186/s12936-021-03593-6

Ejemplares similares